Placebo and nocebo effects in randomized controlled trials: The implications for research and practice

Journal of Pain and Symptom Management

Volumn 46, Issue 5, 2013, Pages 722-730

  Sanderson, Christine ^a,b   Hardy, Janet ^c   Spruyt, Odette ^d   Currow, David C ^b  

^a Calvary Health Care Sydney   (Australia)

^b FLINDERS UNIVERSITY   (Australia)

^c MATER HOSPITAL   (Australia)

^d PETER MACCALLUM CANCER CENTRE   (Australia)

Author keywords

cancer pain; ketamine; nocebo; Placebo; randomized controlled trial methodology

Indexed keywords

CHOLECYSTOKININ; CHOLECYSTOKININ RECEPTOR BLOCKING AGENT; KETAMINE; MISCELLANEOUS DRUGS AND AGENTS; MORPHINE; NALOXONE; NOCEBO; OPIATE; PLACEBO; UNCLASSIFIED DRUG;

ADVANCED CANCER; ADVERSE DRUG REACTION; ANALGESIA; ARTICLE; BACKACHE; CANCER ADJUVANT THERAPY; CANCER PAIN; DEPRESSION; DOSE RESPONSE; DRUG DOSE ESCALATION; DRUG RESPONSE; EVIDENCE BASED PRACTICE; FATIGUE; FIBROMYALGIA; HAWTHORNE EFFECT; HUMAN; IRRITABLE COLON; MEDICAL ETHICS; MEDICAL PRACTICE; NEUROPATHIC PAIN; NOCEBO EFFECT; PALLIATIVE THERAPY; PARKINSON DISEASE; PATIENT CARE; PHASE 3 CLINICAL TRIAL (TOPIC); PLACEBO EFFECT; PSYCHOBIOLOGY; RANDOMIZED CONTROLLED TRIAL (TOPIC); SINGLE DRUG DOSE; TREATMENT RESPONSE;

CANCER PAIN; KETAMINE; NOCEBO; PLACEBO; RANDOMIZED CONTROLLED TRIAL METHODOLOGY;

ANALGESICS; BIOMEDICAL RESEARCH; HUMANS; OUTCOME ASSESSMENT (HEALTH CARE); PAIN; PLACEBO EFFECT; RANDOMIZED CONTROLLED TRIALS AS TOPIC; TREATMENT OUTCOME;

EID: 84886952410     PISSN: 08853924     EISSN: 18736513     Source Type: Journal    
DOI: 10.1016/j.jpainsymman.2012.12.005     Document Type: Article

References (42)

1. J. Hardy, S. Quinn, and B. Fazekas A randomised, double-blind placebo controlled study to assess the efficacy and toxicity of subcutaneous ketamine in the management of cancer pain J Clin Oncol 30 2012 3611 3617
2. G. Hocking, and M.J. Cousins Ketamine in chronic pain management: an evidence-based review Anesth Analg 97 2003 1730 1739
3. R.F. Bell, C. Eccleston, and E.A. Kalso Ketamine as an adjuvant to opioids for cancer pain Cochrane Database Syst Rev 11 2012 CD003351
4. G.J. Ventura, and D.M. Blacklock Intravenous ketamine HCL for treatment of intractable neuropathic cancer pain (INCP) [abstract] Proc Annu Meet Am Soc Clin Oncol 12 1993 A1528
5. Y. Tarumi, S. Watanabe, E. Bruera, and K. Ishitani High dose ketamine in the management of cancer-related neuropathic pain J Pain Symptom Manage 19 2000 405 407
6. P.G. Fine Low-dose ketamine in the management of opioid nonresponsive terminal cancer pain J Pain Symptom Manage 17 1999 296 300
7. S. Mercadante, F. Lodi, M. Sapio, M. Calligara, and R. Serretta Long-term ketamine subcutaneous continuous-infusion in neuropathic cancer pain J Pain Symptom Manage 10 1995 564 568
8. A.L. Cochrane Effectiveness and efficiency: Random reflections on health services 1972 Nuffield Provincial Hospitals Trust London 20-25
9. D. Redelmeier, and V.M. Dickinson Determining whether a patient is feeling better: pitfalls from the science of human perception J Gen Intern Med 26 2011 900 906
10. R. Kunz, and A.D. Oxman The unpredictability paradox: review of empirical comparisons of randomised and non-randomised clinical trials BMJ 317 1998 1185 1190
11. World Medical Association General Assembly, Note of Clarification on Paragraph 29 of the Declaration of Helsinki. 2002. Available from http://www.wma.net/en/30publications/10policies/b3/. Accessed July 12, 2012.
12. R.V. Carlson, K.M. Boyd, and D.J. Webb The revision of the Declaration of Helsinki: past, present and future Br J Clin Pharmacol 57 2004 695 713
13. R. McCarney, J. Warner, and S. Iliffe The Hawthorne effect: a randomised controlled trial BMC Med Res Methodol 7 2007 30
14. D.A. Braunholtz, S.J. Edwards, and R.J. Lilford Are randomized clinical trials good for us (in the short term)? Evidence for a "trial effect" J Clin Epidemiol 54 2001 217 224
15. J.M. Peppercorn, J.C. Weeks, E.F. Cook, and S. Joffe Comparison of outcomes in cancer patients treated within and outside clinical trials: conceptual framework and structured review Lancet 363 2004 263 270
16. M. de la Cruz, D. Hui, H.A. Parsons, and E. Bruera Placebo and nocebo effects in randomized double-blind clinical trials of agents for the therapy for fatigue in patients with advanced cancer Cancer 116 2010 766 774
17. R.H. Dworkin, J. Katz, and M.J. Gitlin Placebo response in clinical trials of depression and its implications for research on chronic neuropathic pain Neurology 65 Suppl 4 2005 S7 S19
18. S.M. Patel, W.B. Stason, and A. Legedza The placebo effect in irritable bowel syndrome trials: a meta-analysis Neurogastroenterol Motil 17 2005 332 340
19. C.G. Goetz, S. Leurgans, R. Raman, and G.T. Stebbins Objective changes in motor function during placebo treatment in PD Neurology 54 2000 710 714
20. G. Chvetzoff, and I.F. Tannock Placebo effects in oncology J Natl Cancer Inst 95 2003 19 29
21. J. Turner, R.A. Devo, J. Loesser, M. Von Korff, and W. Fordyce The importance of placebo effects in pain treatment and research JAMA 271 1994 1609 1614
22. D.D. Price, D.G. Finniss, and F. Benedetti A comprehensive review of the placebo effect: recent advances and current thought Annu Rev Psychol 59 2008 565 590
23. W. Häuser, P. Sarzi-Puttini, T.R. Tölle, and F. Wolfe Placebo and nocebo responses in randomised controlled trials of drugs applying for approval for fibromyalgia syndrome treatment: systematic review and meta-analysis Clin Exp Rheumatol 30 Suppl 74 2012 78 87
24. D. Papadopoulos, and D.D. Mitsikostas A meta-analytic approach to estimating nocebo effects in neuropathic pain trials J Neurol 259 2012 436 447
25. D.D. Mitsikostas, L.I. Mantonakis, and N.G. Chalarakis Nocebo is the enemy, not placebo. A meta-analysis of reported side effects after placebo treatment in headaches Cephalalgia 31 2011 550 561
26. F. Benedetti, E. Carlino, and A. Pollo How placebos change the patient's brain Neuropsychopharmacology 36 2011 339 354
27. J.D. Levine, N.C. Gordon, and H.L. Fields The mechanisms of placebo analgesia Lancet 2 1978 654 657
28. T.D. Wager, J.K. Rilling, and E.E. Smith Placebo-induced changes in fMRI in the anticipation and experience of pain Science 303 2004 1162 1166
29. M.D. Lieberman, J.M. Jarco, and S. Berman The neural correlates of placebo effects: a disruption account Neuroimage 22 2004 447 455
30. P. Petrovic, E. Kalso, K.M. Petersson, and M. Ingvar Placebo and opioid analgesia: imaging a shared network Science 295 2002 1737 1740
31. F. Benedetti The opposite effects of the opiate antagonist naloxone and the cholecystokinin antagonist proglumide on placebo analgesia Pain 64 1996 535 543
32. F. Benedetti, M. Amanzio, and C. Casado Blockade of nocebo hyperalgesia by the cholecystokinin antagonist proglumide Pain 71 1997 135 140
33. L. Lasagna, V.G. Laties, and J.L. Dohan Further studies on the 'pharmacology' of placebo administration J Clin Invest 37 1958 533 537
34. A. Pollo, M. Amanzio, and A. Arslanian Response expectancies in clinical analgesia and their clinical relevance Pain 93 2001 77 84
35. A.J. Barsky, R. Saintfort, M.P. Rogers, and J.F. Borus Nonspecific medication side effects and the nocebo phenomenon JAMA 287 2000 622 627
36. A. Wasan, T.J. Kaptchuk, G. Davar, and R.N. Jamison The association between psychopathology and placebo analgesia in patients with low back pain Pain Med 7 2006 217 228
37. M. Sullivan, M.E. Lynch, A.J. Clark, T. Mankovsky, and J. Sawynok Catastrophizing and treatment outcome: differential impact on response to placebo and active treatment outcome Contemp Hypn 25 2008 129 140
38. A. Kennett, J. Hardy, S. Shah, and R. A'Hern An open study of methotrimeprazine in the management of nausea and vomiting in patients with advanced cancer Support Care Cancer 13 2005 715 721
39. J.R. Hardy, A. O'Shea, and C. White The efficacy of haloperidol in the management of nausea and vomiting in patients with cancer J Pain Symptom Manage 40 2010 111 116
40. J.D. Bremner, J.H. Krystal, and F.W. Putnam Measurement of Dissociative States Scale with the Clinician-Administered Dissociative States Scale (CADSS) J Trauma Stress 11 1998 125 136
41. M.C. Irizarry, D.J. Webb, and Z. Ali Predictors of placebo response in pooled lamotrigine neuropathic pain clinical trials Clin J Pain 25 2009 469 476
42. T. To, M. Agar, and T. Shelby-James Off-label prescribing in palliative care - a cross-sectional national survey of Palliative Medicine doctors Palliat Med 2012 Nov 5 [Epub ahead of print]